2020
PARP inhibition in homologous-recombination-deficient early-stage breast cancer
Pusztai L. PARP inhibition in homologous-recombination-deficient early-stage breast cancer. Annals Of Oncology 2020, 32: 4-5. PMID: 33181269, DOI: 10.1016/j.annonc.2020.11.001.Peer-Reviewed Original Research
2017
Intratumor Heterogeneity of Homologous Recombination Deficiency in Primary Breast Cancer
von Wahlde MK, Timms KM, Chagpar A, Wali VB, Jiang T, Bossuyt V, Saglam O, Reid J, Gutin A, Neff C, Lanchbury JS, Hatzis C, Hofstatter E, Pusztai L. Intratumor Heterogeneity of Homologous Recombination Deficiency in Primary Breast Cancer. Clinical Cancer Research 2017, 23: 1193-1199. PMID: 27601588, DOI: 10.1158/1078-0432.ccr-16-0889.Peer-Reviewed Original Research